Outcomes of intravascular brachytherapy for recurrent drug‐eluting in‐stent restenosis

Abstract

VBT can improve the treatment of recurrent DES-ISR, but TLF occurs in approximately one in three patients at 2 years. Initial presentation with ACS was associated with higher TLF and the use of IVUS with a trend for lower incidence of TLF.